| [1] |
Neumann JA, Garrigues GE, Brigman BE, et al. Synovial chondromatosis[J/OL]. JBJS Rev, 2016, 4(5). DOI: 10.2106/jbjs.rvw.o.00054.
|
| [2] |
Habusta SF, Tuck JA. Synovial Chondromatosis[M]. Treasure Island (FL): Stat Pearls Publishing, 2022.
|
| [3] |
Evans S, Boffano M, Chaudhry S, et al. Synovial chondrosarcoma arising in synovial chondromatosis[J/OL]. Sarcoma, 2014, 2014: 647939. DOI: 10.1155/2014/647939.
|
| [4] |
胡海涛，贺加明，马为斌，等. 关节镜下治疗膝关节腘窝处滑膜软骨瘤病1例[J/CD]. 中华关节外科杂志(电子版), 2019, 13(3): 380－382.
|
| [5] |
Gambarotti M, Pacheco M, Ruengwanichayakun P, et al. Synovial chondrosarcoma: a single-institution experience with molecular investigations and review of the literature[J]. Histopathology, 2020, 77(3): 391－401.
|
| [6] |
Buddingh EP, Krallman P, Neff JR, et al. Chromosome 6 abnormalities are recurrent in synovial chondromatosis[J]. Cancer Genet Cytogenet, 2003, 140(1): 18－22.
|
| [7] |
Fujita S, Iizuka T, Yoshida H, et al. Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint. Report of a case[J]. Int J Oral Maxillofac Surg, 1997, 26(4): 258－259.
|
| [8] |
Yamane S, Reddi AH. Induction of chondrogenesis and superficial zone protein accumulation in synovial side population cells by BMP-7 and TGF-beta1[J]. J Orthop Res, 2008, 26(4): 485－492.
|
| [9] |
Watson RS, Gouze E, Levings PP, et al. Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo[J]. Lab Invest, 2010, 90(11): 1615－1627.
|
| [10] |
Yoshitake H, Kayamori K, Wake S, et al. Biomarker expression related to chondromatosis in the temporomandibular joint[J]. Cranio, 2021, 39(4): 362－366.
|
| [11] |
韩玮华，罗海燕，郭传瑸，等. 软骨寡聚基质蛋白在颞下颌关节滑膜软骨瘤病中的表达[J]. 北京大学学报(医学版)，2021，53(1)：34－39.
|
| [12] |
Zhao W, Ruan Y, Zhang W, et al. Synovial chondromatosis of the temporomandibular joint with 400 loose bodies: a case report and literature review[J/OL]. J Int Med Res, 2021, 49(3): 3000605211000526. DOI: 10.1177/03000605211000526.
|
| [13] |
Moorthy V, Tay KS, Koo K. Arthroscopic treatment of primary synovial chondromatosis of the ankle: acase report and review of literature[J]. J Orthop Case Rep, 2020, 10(6): 54－59.
|
| [14] |
Sato J, Segami N, Suzuki T, et al. The expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in chondrocytes in synovial chondromatosis of the temporomandibular joint. report of two cases[J]. Int J Oral Maxillofac Surg, 2002, 31(5): 532－536.
|
| [15] |
Tojyo I, Yamaguti A, Ozaki H, et al. The expression of fibroblast growth factor receptor-3 in synovial osteochondromatosis of the temporomandibular joint[J]. Arch Oral Biol, 2004, 49(7): 591－594.
|
| [16] |
Li Y, Cai H, Fang W, et al. Fibroblast growth factor 2 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint[J]. J Oral Pathol Med, 2014, 43(5): 388－394.
|
| [17] |
Li Y, El Mozen LA, Cai H, et al. Transforming growth factor beta 3 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint[J/OL]. Sci Rep, 2015, 5: 8843. DOI: 10.1038/srep08843.
|
| [18] |
Xie Y, Zinkle A, Chen L, et al. Fibroblast growth factor signalling in osteoarthritis and cartilage repair[J]. Nat Rev Rheumatol, 2020, 16(10): 547－564.
|
| [19] |
Nakanishi S, Sakamoto K, Yoshitake H, et al. Bone morphogenetic proteins are involved in the pathobiology of synovial chondromatosis[J]. Biochem Biophys Res Commun, 2009, 379(4): 914－919.
|
| [20] |
Guijarro-Martínez R, Puche Torres M, Marqués Mateo M, et al. Bilateral synovial chondromatosis of the temporomandibular joint[J]. J Craniomaxillofac Surg, 2011, 39(4): 261－265.
|
| [21] |
Wake M, Hamada Y, Kumagai K, et al. Up-regulation of interleukin-6 and vascular endothelial growth factor-a in the synovial fluid of temporomandibular joints affected by synovial chondromatosis[J]. Br J Oral Maxillofac Surg, 2013, 51(2): 164－169.
|
| [22] |
Kristensen KD, Alstergren P, Stoustrup P, et al. Cytokines in healthy temporomandibular joint synovial fluid[J]. J Oral Rehabil, 2014, 41(4): 250－256.
|
| [23] |
罗韬. IL-6及TGF-β1促膝关节滑膜细胞向软骨细胞转化的研究[D]．衡阳：南华大学，2020.
|
| [24] |
韩玮华，罗海燕，郭传瑸，等. 软骨寡聚基质蛋白在颞下颌关节滑膜软骨瘤病中的表达[J]. 北京大学学报(医学版), 2021, 53(1): 34－39.
|
| [25] |
Wilms CT, Heim N, Teschke M, et al. Synovial chondromatosis of the temporomandibular joint: immunohistochemical examinations regarding the role of insulin-like growth factors and their binding proteins in the etiology of this disease[J]. J Craniomaxillofac Surg, 2017, 45(2): 198－202.
|
| [26] |
Adelani MA, Wupperman RM, Holt GE. Benign synovial disorders[J]. J Am Acad Orthop Surg, 2008, 16(5): 268－275.
|
| [27] |
Nishiyama M, Nozawa M, Ogi N, et al. Computed tomographic features of synovial chondromatosis of the temporomandibular joint with a few small calcified loose bodies[J]. Oral Radiol, 2021, 37(2): 236－244.
|
| [28] |
Liu X, Wan S, Shen P, et al. Diagnostic accuracy of synovial chondromatosis of the temporomandibular joint on magnetic resonance imaging[J/OL]. PLoS One, 2019, 14(1): e0209739. DOI: 10.1371/journal.pone.0209739.
|
| [29] |
Boninsegna E, Fassio A, Testoni M, et al. Radiological features of knee joint synovial chondromatosis[J]. Reumatismo, 2019, 71(2): 81－84.
|
| [30] |
Maghear L, Serban O, Papp I, et al. Multimodal ultrasonographic evaluation in a case with unossified primary synovial osteochondromatosis[J]. Med Ultrason, 2018, 20(4): 527－530.
|
| [31] |
Beger AW, Millard JA, Bresnehan A, et al. Primary synovial chondromatosis: an elemental investigation of a rare skeletal pathology[J]. Folia Morphol, 2022, 81(3): 685－693.
|
| [32] |
Aydogan NH, Kocadal O, Ozmeric A, et al. Arthroscopic treatment of a case with concomitant subacromial and subdeltoid synovial chondromatosis and labrum tear[J/OL]. Case Rep Orthop, 2013, 2013: 636747. DOI: 10.1155/2013/636747.
|
| [33] |
Tutun S, Ozgonenel L, Cetin E, et al. Two rare involvement sites: synovial chondromatosis[J]. Rheumatol Int, 2011, 31(5): 687－689.
|
| [34] |
Chen MJ, Yang C, Cai XY, et al. Synovial chondromatosis in the inferior compartment of the temporomandibular joint: different stages with different treatments[J/OL]. J Oral Maxillofac Surg, 2012, 70(1): e32－e38. DOI: 10.1016/j.joms.2011.07.014.
|
| [35] |
Shpitzer T, Ganel A, Engelberg S. Surgery for synovial chondromatosis. 26 cases followed up for 6 years[J]. Acta Orthop Scand, 1990, 61(6): 567－569.
|
| [36] |
Wengle LJ, Hauer TM, Chang JS, et al. Systematic arthroscopic treatment of synovial chondromatosis of the knee[J/OL]. Arthrosc Tech, 2021, 10(10): e2265－e2270. DOI: 10.1016/j.eats.2021.07.001.
|
| [37] |
Lim SJ, Chung HW, Choi YL, et al. Operative treatment of primary synovial osteochondromatosis of the hip[J]. J Bone Joint Surg Am, 2006, 88(11): 2456－2464.
|
| [38] |
Kondo M, Yamaoka K, Sakata K, et al. Contribution of the interleukin-6/STAT-3 signaling pathway to chondrogenic differentiation of human mesenchymal stem cells[J]. Arthritis Rheumatol, 2015, 67(5): 1250－1260.
|
| [39] |
Compan V, Baroja-Mazo A, López-Castejón G, et al. Cell volume regulation modulates NLRP3 inflammasome activation[J]. Immunity, 2012, 37(3): 487－500.
|
| [40] |
谢俊雄，邓志钦，张宁峰，等. 关节腔渗透压调控骨关节炎的研究进展[J]. 生物骨科材料与临床研究，2021, 18(1): 55－58.
|